Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D; Humblet Y; Siena S; Khayat D; Bleiberg H; Santoro A; Bets D; Mueser M; Harstrick A; Verslype C; Chau I; Van Cutsem E; The New England Journal Of Medicine, 2004, vol. 351, issue 4, p 337, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation